Neurology and neurologic practice in China

Neurology

Volumn 77, Issue 22, 2011, Pages 1986-1992

  Shi, Fu Dong ^a,b   Jia, Jian Ping ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTIDEPRESSANT AGENT; BETA1A INTERFERON; BETASERSON; HERBACEOUS AGENT; IMMUNOGLOBULIN; NEUROLEPTIC AGENT; NEUROPROTECTIVE AGENT; PROTEIN HYDROLYSATE; RITUXIMAB; SNAKE VENOM; STEROID; UNCLASSIFIED DRUG; UROKINASE;

ACCESS TO INFORMATION; ACUPUNCTURE; AGING; ALZHEIMER DISEASE; ARTICLE; ATTITUDE TO HEALTH; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHINA; CLINICAL PRACTICE; DEPRESSION; DOCTOR PATIENT RELATION; DRUG COST; DRUG INDUSTRY; EARLY INTERVENTION; ECONOMIC ASPECT; HEALTH CARE POLICY; HEALTH INSURANCE; HISTORY OF MEDICINE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MEDICAL EDUCATION; MEDICAL LITERATURE; MILD COGNITIVE IMPAIRMENT; MOBILIZATION; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGY; PARKINSON DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; SPECIALIZATION; STROKE; TREATMENT PLANNING; URBANIZATION;

EID: 82955225288     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31823a0ed3     Document Type: Article

References (28)

1. Ferguson ME. China Medical Board and Peking Union Medical College. New York: China Medical Board of New York, Inc.; 1970.
2. Wang XD. Brief history of the development neurology in China. J Chin Neurol Psychiatry 1995;28:158-161.
3. Guo YP, Zhao BX. Past, present and future of neurology in China. J Chin Neurol Psychiatry 1995;28:137-138.
4. Wang XP, Zhang WF, Huang HY, Preter M. Neurology in the People's Republic of China: An update. Eur Neurol 2010;64:320-324.
5. Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China: Twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke 2008;39: 1668-1674.
6. Liu M, Wu B, Wang WZ, et al. Stroke in China: Epidemiology, prevention, and management strategies. Lancet Neurol 2007;6:456-464. (Pubitemid 46551849)
7. Cyranoski D. China tackles surge in mental illness. Nature 2010;468:145.
8. Wang F, Shu C, Jia L, et al. Exploration of 16 candidate genes identifies the association of IDE with Alzheimer's disease in Han Chinese. Neurobiol Aging Epub 2010 Sep 27.
9. Dong MJ, Peng B, Lin XT, et al. The prevalence of dementia in the People's Republic of China: A systematic analysis of 1980-2004 studies. Age Ageing 2007;36:619-624. (Pubitemid 350258969)
10. Zhang ZX, Zahner GE, Roman GC, et al. Dementia subtypes in China: Prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol 2005;62:447-453. (Pubitemid 40349481)
11. Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005;62: 1160-1163. (Pubitemid 41043744)
12. Lopez OL, Kuller LH, Becker JT, et al. Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol 2007;64:416-420. (Pubitemid 46425698)
13. Guo Y, Shibuya K, Cheng G, Rao K, Lee L, Tang S. Tracking China's health reform. Lancet 2010;375:1056-1058.
14. Yip WC, Hsiao W, Meng Q, Chen W, Sun X. Realignment of incentives for health-care providers in China. Lancet 2010;375:1120-1130.
15. Editorial. Chinese doctors are under threat. Lancet 2010; 376:657.
16. Guo Y, Shibuya K, Cheng G, Rao K, Lee L, Tang S. Tracking China's health reform. Lancet 2010;375:1056-1058.
17. Kim NH, Kim HJ, Cheong HK, et al. Prevalence of multiple sclerosis in Korea. Neurology 2010;75:1432-1438.
18. Cheng Q, Miao L, Zhang J, et al. Clinical features of patients with multiple sclerosis from a survey in Shanghai. China Mult Scler 2008;14:671-678. (Pubitemid 351954410)
19. Tsai CP, Yuan CL, Yu HY, Chen C, Guo YC, Shan DE. Multiple sclerosis in Taiwan. J Chin Med Assoc 2004;67: 500-505. (Pubitemid 40069082)
20. Faulkner LR, Juul D, Pascuzzi RM, et al. Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties. Neurology 2010;75:1110-1117.
21. Bailey P. The past, present and future of neurology in the United States: 1951. Neurology 2011;76:18-22.
22. Hao J, Liu R, Piao W, et al. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 2010;207:1907-1921.
23. Hao JH, Campagnolo DI, Liu R, et al. IL-2/IL-2 mAb therapy induces target organ NK cells that inhibit autoimmune disease. Ann Neurol 2011;69:721-734.
24. Wells WA. The returning tide: How China, the world's most populous country, is building a competitive research base. J Exp Med 2007;204:210-235. (Pubitemid 46294538)
25. Cyranoski D. Stem-cell therapy faces more scrutiny in China. Nature 2009;459:146-147.
26. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342. (Pubitemid 23103964)
27. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): A randomised pilot trial. Lancet Neurol 2008;7:391-399.
28. Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010;41:2108-2129.